Suppr超能文献

通过抗T细胞受体可变区试剂检测发现T细胞淋巴瘤中V基因使用受限。

Restricted V gene usage in T-cell lymphomas as detected by anti-T-cell receptor variable region reagents.

作者信息

Poppema S, Hepperle B

机构信息

Department of Laboratory Medicine, Cross Cancer Institute, Edmonton, Alberta, Canada.

出版信息

Am J Pathol. 1991 Jun;138(6):1479-84.

Abstract

Monoclonal antibodies reactive with variable regions of the human T-cell receptor (TCR) may be used to detect populations of T lymphocytes with restricted V gene usage. The authors have studied a series of 44 T-cell lymphomas with a panel of seven reagents reactive with four different TCR beta-chain variable region families. The authors found that, with this limited panel, restricted V gene usage of the neoplastic cells could be demonstrated in 29% of TCR-positive lymphomas. Whereas this is somewhat higher than expected, no preferential use of specific families could be demonstrated. An additional, unexpected finding was that most large cell T-cell lymphomas did not express TCR despite the presence of cytoplasmic CD3. The findings indicate that with a somewhat expanded panel it should be feasible to demonstrate restricted V gene usage as an indicator of clonality in a majority of T-cell lymphomas in a manner similar to the application of anti-immunoglobulin subclass antibodies in the diagnosis of clonal B cell proliferations.

摘要

与人T细胞受体(TCR)可变区反应的单克隆抗体可用于检测V基因使用受限的T淋巴细胞群体。作者使用一组七种与四个不同TCRβ链可变区家族反应的试剂,研究了一系列44例T细胞淋巴瘤。作者发现,使用这一有限的试剂组,在29%的TCR阳性淋巴瘤中可证明肿瘤细胞存在V基因使用受限。虽然这略高于预期,但未显示出对特定家族的优先使用。另一个意外发现是,尽管存在细胞质CD3,但大多数大细胞T细胞淋巴瘤不表达TCR。这些发现表明,通过稍微扩大试剂组,以类似于应用抗免疫球蛋白亚类抗体诊断克隆性B细胞增殖的方式,证明V基因使用受限作为大多数T细胞淋巴瘤克隆性的指标应该是可行的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d0a/1886411/ce568cd0f575/amjpathol00102-0185-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验